Immunotherapy Outcomes in Advanced Melanoma in Relation to Age.

CONCLUSION: Aging does not seem to affect response to checkpoint inhibitors. Elderly patients with metastatic melanoma should be treated similarly to younger patients. PMID: 32097116 [PubMed - as supplied by publisher]
Source: The Permanente journal - Category: General Medicine Tags: Perm J Source Type: research